Academy of Finland
Funding decision
Name Leppä, Sirpa
Organisation Helsinki University Central Hospital
Project title Precision medicine in B-cell lymphomas
Decision No. 311171
Decision date 28.04.2017
Funding,period 01.09.2017 - 31.08.2021
Funding 440 679
WebFOCUS Report
Project description
Aggressive B-cell lymphomas are heterogeneous but potentially curable cancers even in advanced stage and among all age groups. However, when treatment fails, outcome is poor. Our major objective is to advance lymphoma therapies towards precision medicine by designing and conducting biomarker-driven academic trials in patients with high risk disease. An important secondary objective is to identify biomarkers that can be used in response evaluation, post-treatment monitoring and precision treatment decisions.